iPSC Derived Cell Therapies for Cancer

Cell therapies derived from induced Pluripotent Stem Cell (iPSC) technology is emerging in cancer therapeutics. For example, iPSCs allow the development of immune therapies and drug screening programs in the genetic background of the patient. Discover the latest research on iPSC derived cell therapies for cancer here.

April 30, 2020
Preprint
Open Access

Genome-Wide Meta-Analysis Identifies a S1PR1 Genomic Region Associated with Microtubule Targeting Agent-Induced Sensory Peripheral Neuropathy

MedRxiv : the Preprint Server for Health Sciences
K. C. ChuaDeanna L Kroetz
June 24, 2020
Open Access

Plasmodium vivax liver stage assay platforms using Indian clinical isolates

Malaria Journal
Pradeep A SubramaniVaradharajan Sundaramurthy
July 1, 2020

Neural In Vitro Models for Studying Substances Acting on the Central Nervous System

Handbook of Experimental Pharmacology
Ellen FritscheBarbara Viviani
April 12, 2020

Characterization of human induced pluripotent stem cells carrying homozygous RB1 gene deletion

Genes to Cells : Devoted to Molecular & Cellular Mechanisms
Xiaoyue DengSumiko Watanabe
May 16, 2020

Recent technological advancements in stem cell research for targeted therapeutics

Drug Delivery and Translational Research
Nilesh RaiVibhav Gautam
May 1, 2020

Induced pluripotent stem cell-derived myeloid cells expressing OX40 ligand amplify antigen-specific T cells in advanced melanoma

Pigment Cell & Melanoma Research
Toshihiro KimuraHironobu Ihn
April 22, 2020
Preprint
Open Access

Sequential CRISPR gene editing in human iPSCs charts the clonal evolution of leukemia

BioRxiv : the Preprint Server for Biology
T. WangEirini P Papapetrou
August 11, 2020
Open Access

Intensity normalization methods in brain FDG-PET quantification

NeuroImage
Francisco J López-GonzálezPablo Aguiar
April 2, 2020

Marine biomaterials: Biomimetic and pharmacological potential of cultivated Aplysina aerophoba marine demosponge

Materials Science & Engineering. C, Materials for Biological Applications
Björn BinnewergHermann Ehrlich
May 13, 2020
Review
Open Access

NK Cell-Based Immunotherapies in Cancer

Immune Network
Min Hwa ShinKyung-Mi Lee
July 29, 2020
Preprint
Open Access

Deconvolution of cellular subsets in human tissue based on targeted DNA methylation analysis at individual CpG sites

BioRxiv : the Preprint Server for Biology
M. SchmidtWolfgang Wagner
April 30, 2020

Microphysiological Modeling of the Human Endometrium

Tissue Engineering. Part a
Hannes CampoJ Julie Kim
May 8, 2020
Review

Development of a new assessment for cardio-oncology and its international trend

Nihon yakurigaku zasshi. Folia pharmacologica Japonica
Ayano Satsuka, Yasunari Kanda
June 21, 2020

Genomewide Meta-Analysis Validates a Role for S1PR1 in Microtubule Targeting Agent-Induced Sensory Peripheral Neuropathy

Clinical Pharmacology and Therapeutics
Katherina C ChuaDeanna L Kroetz
June 2, 2020
Review
Open Access

The Advent of CAR T-Cell Therapy for Lymphoproliferative Neoplasms: Integrating Research Into Clinical Practice

Frontiers in Immunology
Marco CerranoBenedetto Bruno

Sign up to follow this feed and discover related papers.

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Biosensors for Cancer Detection

Biosensors are devices that are designed to detect a specific biological analyte by essentially converting a biological entity (ie, protein, DNA, RNA) into an electrical signal that can be detected and analyzed. The use of biosensors in cancer detection and monitoring holds vast potential. Biosensors can be designed to detect emerging cancer biomarkers and to determine drug effectiveness at various target sites. Biosensor technology has the potential to provide fast and accurate detection, reliable imaging of cancer cells, and monitoring of angiogenesis and cancer metastasis, and the ability to determine the effectiveness of anticancer chemotherapy agents.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Brain Stem Neoplasms

Brain Stem Neoplasms are cancers that are common in children and can occur in the mesencephalon, pons or medulla oblongata. Discover the latest research on Brain Stem Neoplasms here.

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.

CAR-T cells

Chimeric antigen receptor (CAR) T cells are cells that are genetically engineered to recognize and target specific proteins. The ability of these cells to recognize cancer antigens and eliminate tumor cells have transformed cancer immunotherapy approaches. Here is the latest research on CAR-T cells.

Cancer Cell Invasion: Nanomedicine

Nanomedicine is a promising alternative for cancer detection and therapy that utilizes nanoparticles, such as liposomes. Nanoparticles can potentially target cancer cell invasion and metastasis. Discover the latest research on Cancer Cell Invasion: Nanomedicine here.

Cancer Disparities

Cancer disparities refers to differences in cancer outcomes (e.g., number of cancer cases, related health complications) across population groups.

Cancer Genomics

Cancer genomics employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research here.

Cancer Immunotherapy

Cancer immunotherapy is an important field of research that is looking at controlling cancer and tumor growth by activating the individuals own immune system. Recent studies have utilized chimeric antigen receptor t-cell therapy, immune checkpoint inhibitors and neoantigen vaccines. Discover the latest research on cancer immunotherapy here.

© 2020 Meta ULC. All rights reserved
/feed-previews/ipsc-derived-cell-therapies-for/b4ce42ee-0240-4764-ad4b-9fb5c8a47d5b